Prognostic impact of salvage treatment on hearing recovery in patients with sudden sensorineural hearing loss refractory to systemic corticosteroids: A retrospective observational study.

[1]  L. Giacomelli,et al.  Uni- and multivariate models for investigating potential prognostic factors in idiopathic sudden sensorineural hearing loss , 2015, European Archives of Oto-Rhino-Laryngology.

[2]  Y. Tabata,et al.  A randomized controlled clinical trial of topical insulin-like growth factor-1 therapy for sudden deafness refractory to systemic corticosteroid treatment , 2014, BMC Medicine.

[3]  O. Guntinas-Lichius,et al.  Prognostic impact of standard laboratory values on outcome in patients with sudden sensorineural hearing loss , 2014, BMC Ear, Nose and Throat Disorders.

[4]  I. Varela-Nieto,et al.  IGF-I deficiency and hearing loss: molecular clues and clinical implications. , 2013, Pediatric endocrinology reviews : PER.

[5]  J. Ito,et al.  Insulin-like growth factor 1 inhibits hair cell apoptosis and promotes the cell cycle of supporting cells by activating different downstream cascades after pharmacological hair cell injury in neonatal mice , 2013, Molecular and Cellular Neuroscience.

[6]  R. Filipo,et al.  Intratympanic steroid therapy in moderate sudden hearing loss: A randomized, triple‐blind, placebo‐controlled trial , 2013, The Laryngoscope.

[7]  I. Castilla-Cortázar,et al.  Human conditions of insulin-like growth factor-I (IGF-I) deficiency , 2012, Journal of Translational Medicine.

[8]  E. Hultcrantz,et al.  Corticosteroid Treatment of Idiopathic Sudden Sensorineural Hearing Loss: Randomized Triple-Blind Placebo-Controlled Trial , 2012, Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology.

[9]  Steven R. Brown,et al.  Clinical Practice Guideline , 2011, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[10]  D. Reda,et al.  Oral vs intratympanic corticosteroid therapy for idiopathic sudden sensorineural hearing loss: a randomized trial. , 2011, JAMA.

[11]  Y. Tabata,et al.  Topical insulin-like growth factor 1 treatment using gelatin hydrogels for glucocorticoid-resistant sudden sensorineural hearing loss: a prospective clinical trial , 2010, BMC medicine.

[12]  Linda M Luxon,et al.  Sudden sensorineural hearing loss , 2010, The Lancet.

[13]  Chi-Te Wang,et al.  Correlation between Audiovestibular Function Tests and Hearing Outcomes in Severe to Profound Sudden Sensorineural Hearing Loss , 2009, Ear and hearing.

[14]  Y. Tabata,et al.  Insulin-like growth factor 1 treatment via hydrogels rescues cochlear hair cells from ischemic injury , 2008, Neuroreport.

[15]  S. Rauch.  Clinical practice. Idiopathic sudden sensorineural hearing loss. , 2008, The New England journal of medicine.

[16]  Y. Tabata,et al.  Novel Therapy for Hearing Loss: Delivery of Insulin-Like Growth Factor 1 to the Cochlea Using Gelatin Hydrogel , 2007, Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology.

[17]  T. Nakashima,et al.  Thirty-year trends in sudden deafness from four nationwide epidemiological surveys in Japan , 2007, Acta oto-laryngologica.

[18]  Y. Tabata,et al.  Cochlear Protection by Local Insulin‐Like Growth Factor‐1 Application Using Biodegradable Hydrogel , 2006, The Laryngoscope.

[19]  F. Byl.  Sudden hearing loss: Eight years' experience and suggested prognostic table , 1984, The Laryngoscope.

[20]  F. B. Simmons,et al.  Natural History of Sudden Sensorineural Hearing Loss , 1977, The Annals of otology, rhinology, and laryngology.